Joan D’souza’s treatment experience includes oncology, dermatology, pain management, infectious disorders, vaccines, drug-device combinations, neurology, cardiovascular gastroenterology, respiratory, orphan diseases, rare diseases, and diabetes.
Joan currently is active in several ISoP special interest groups, including Risk communication (secretary), Medical devices, Geriatric pharmacovigilance, Vaccination, Medication error, and Ecopharmacovigilance. Joan has actively participated in the Pharmacovigilance and Medical devices special interest groups of the European Medical Writers Association. She has frequently written for the ISoP Drug Safety Journal and the European Medical Writers Association Journal. She is also a member of PIPA, UK and RQA, UK. She was also the past-president of ISOP Switzerland and Austria Chapter. She is currently pursuing a Masters in Pharmacovigilance and Pharmacoepidemiology at Eu2P and preparing for her PhD in drug- device combination regulations at the University of Strasbourg.
Joan is a lawyer (JD licensed to practice law in Minnesota, US) and a physician. She earned a Dean’s List designation for academic performance after completing a post-baccalaureate clinical research program at the University of Cincinnati in the US. Joan also obtained an advanced diploma in pharmacovigilance with software training. She also runs a non-profit women’s association called VinspireU, that helps women to settle overseas. Joan resides in Switzerland and has a supportive husband and two beautiful girls. During her free time, she likes singing, playing piano, or hiking with her family.
Jon Henrich is a senior industry leader focused on Captive Sales Finance business domain. He joins Tech Mahindra after a 33 year career at Ford Credit and Ford Motor Company. At Ford Credit Jon oversaw Consumer Risk Management globally introducing model driven and centralized origination and servicing technologies and managed Ford Credit’s Fintech & Mobility group leading the acquisition and launch of Canvas, a vehicle subscription business in San Francisco, Ca.
He also served as Director of Six Sigma and Quality and in numerous operational and marketing roles. While at Ford, Jon served as Chief Product Officer at Ford Commercial Solutions and Director of Product for FordPass.
Natasha is a seasoned, dynamic learning development and eCOA/ePRO professional with ten years in the clinical trials industry. Her expertise within the field is technical product training, and she has facilitated hands-on, instructor-led trainings to over 300 sites throughout her career.
Dr. Staffaroni is a clinical neuropsychologist and Associate Professor at the UCSF Memory and Aging Center. His research focuses on improving early detection, prognosis, and monitoring of neurodegenerative diseases through a combination of clinical tests, neuroimaging, and blood-based biomarkers. He leads studies of remote digital data collection in frontotemporal dementia using smartphone assessments and sensor technologies.
Kyle has been dedicated to advancing the voice of the patient through the promise of ePRO/eCOA since 2007, in that time helping deliver over 500 successful trials for CROs and Pharmaceutical companies globally. He is a recognized expert for implementing innovative and patient centric ePRO/eCOA solutions with an aim to achieve sponsor confidence and study success across all phases of clinical trials.
As the Director of Account Management & Sr. Account Strategist at SCORR, Tess is a consummate team player, contributing her expertise and attention to detail at every stage of marketing ideation and execution. Earning her Executive MBA while working at a senior level, Tess is undeniably tenacious, which translates into carefully considered strategies and long-lasting relationships for her clients. With a dynamic portfolio of clients across the life sciences spectrum, Tess is seasoned in guiding companies through everything from corporate branding initiatives to targeted strategies to ensure clients maximize ROI.
Mihad has a wealth of product experience. He has spent the last 10 years leading the development of data-driven products for the clinical trials sector. Working with leading academic and commercial research organisations, he managed the development of a suite of data-driven products on the EMIS-X Analytics platform.
Jenny is the Product Owner for Pathway, overseeing the quality and usability of the product. She determines what features are developed and when they are released.
Dr Ian Wood is an active NHS GP and a Clinical Director at EMIS
As a clinician with a background in both General Practice, digital therapeutics and mental health, Ian has a unique experience in how technology can be used to enhance and enable person-centred care.
He has led the implementation of groundbreaking treatments across the NHS and is driven by a passion for using technology to transform traditional care pathways to not only benefit patients but also to empower clinicians and improve the overall efficiency of the NHS.
As the Director of Partners and Life Sciences at EMIS, Jamie leads a team of professionals who are passionate about transforming healthcare through data and technology. He develops and manages partnerships with life sciences companies, research institutions, and government agencies, leveraging EMIS’s data platform and solutions.
